Home > Name List By h > HUMAN M-CSF

CAS No 81627-83-0 , HUMAN M-CSF

  • Name: HUMAN M-CSF
  • Synonyms: colony-stimulatingfactor1;monocytecolony-stimulatingfactor;NATURAL HUMAN MACROPHAGE-COLONY STIMULATING FACTOR;csf-1;NATURAL HUMAN CSF-1;cytokines,macrophagecolony-stimulatingfactor;HUMAN M-CSF;RHM-CSF;RECOMBINANT HUMAN M-CSF;
  • CAS Registry Number:
  • Safety Statements: 22-24/25
  • Molecular Weight: 0
  • InChI: InChI=1S/C18H17Cl2N3O3.H2O/c1-23(17(25)10-22-16(24)9-21)15-7-6-11(19)8-13(15)18(26)12-4-2-3-5-14(12)20;/h2-8H,9-10,21H2,1H3,(H,22,24);1H2
  • Molecular Formula: C18H19Cl2N3O4
  • Molecular Structure:CAS No:81627-83-0 HUMAN M-CSF

Related products

Search by region :

Select to

81627-83-0 COLONY STIMULATING FACTOR- MACROPHAGE

  • Hong kong Advanced Technology & Industrial Co., Ltd. [Manufacturer]
  • Tel: (852) 2390 2293/ (852) 2394 5546
  • Fax: (852) 2789 8314
  • Address: Unit B, 1/F., Cheong Shing Bldg.,
    17 Walnut St., Tai Kok Tsui, Kln,
    Hong Kong null,nullHong kong
Contact Supplier

81627-83-0 COLONY-STIMULATINGFACTOR1

  • China Nanjing Chemlin Chemical Industry Co.,Ltd. [Manufacturer]
  • Tel: +86 25 8369-7070/ +86 138 51816776 (Mobile)
  • Fax: +86 25 8345-3275
  • Address: Rm.902 Longyin Plaza,
    No. 217 Zhongshan Rd.
    (N)Nanjing 210009,China null,nullChina
Contact Supplier

81627-83-0 HUMAN M-CSF

  • United States PEPROTECH [Manufacturers]
  • Tel: 800 436 9910
  • Fax: (609) 497-0321
  • Address: P.O. Box 275 Rocky Hill, NJ 08553 Rocky Hill,Rocky HillUnited States
Contact Supplier

81627-83-0 HUMAN M-CSF

  • China BIOSOURCE [Importer/Exporter]
  • Tel: (86-10) 5808-5888
  • Fax: (86-10) 6780-6535
  • Address: No.7, Rong Chang East Street Long Sheng Industry Park, Building 203 BDA Beijing, 100176 Beijing,BeijingChina
Contact Supplier

Select to

1/1
References of HUMAN M-CSF
Title: Macrophage Colony-Stimulating Factor
CAS Registry Number: 81627-83-0
CAS Name: Colony-stimulating factor 1
Synonyms: M-CSF; CSF-1
Literature References: Species specific hematopoietic growth factor which stimulates the development of committed progenitor cells to monocytes/macrophages. Also potentiates phagocytic activity and monocyte-mediated tumor cell cytotoxicity. Heavily glycosylated homodimer; produced in response to specific activating agents by a variety of cell types including monocytes, fibroblasts and endothelial cells. In humans, several molecular species have been identified which are produced via alternative splicing mechanisms from a single-copy gene. The primary transcripts include a 90 kDa glycoprotein, which is the principle form detected in serum and urine, and a fully bioactive, membrane-associated 40-50 kDa dimer. Murine M-CSF is similar to the human long form. Isoln from human urine: E. R. Stanley et al., Fed. Proc. 34, 2272 (1975); from cultured human pancreatic carcinoma cells: M. Wu et al., J. Biol. Chem. 254, 6226 (1979). Purification of murine M-CSF: E. R. Stanley, P. M. Heard, ibid. 252, 4305 (1977). Characterization of human M-CSF: S. K. Das et al., Blood 58, 630 (1981); K. Motoyoshi et al., ibid. 60, 1378 (1982). Cloning of short form (human clone pcCSF-17): E. S. Kawasaki et al., Science 230, 291 (1985); of long form (human clone p3ACSF-69): G. G. Wong et al., ibid. 235, 1504 (1987). Review of molecular biology: E. S. Kawasaki, M. B. Ladner, Immunol. Ser. 49, 155-176 (1990); of bioactivity and clinical studies: D. H. Munn, N.-K. V. Cheung, Semin. Oncol. 19, 395-407 (1992).
 
Derivative Type: Mirimostim
CAS Registry Number: 121547-04-4
CAS Name: 1-214-Colony-stimulating factor 1 (human clone p3ACSF-69 protein moiety reduced) homodimer
Trademarks: Costilate (Green Cross); Leukoprol (Morinaga)
 
Derivative Type: 4-221-Colony-stimulating factor 1 (human clone p3ACSF-69 protein moiety reduced)
CAS Registry Number: 117276-75-2
Literature References: Nonglycosylated, 218 amino acid polypeptide produced in E. coli by recombinant DNA technology. Prepn and renaturation into bioactive homodimer: R. Halenbeck et al., BioTechnology 7, 710 (1989). Clinical evaluation in invasive fungal infections: J. Nemunaitis et al., Blood 82, 1422 (1993). Immunomodulatory effects and pharmacokinetics: R. M. Bukowski et al., J. Clin. Oncol. 12, 97 (1994).
 
Therap-Cat: Immunomodulator.
Keywords: Immunomodulator.